DNA Repair Activity in the Skin of Day and Night Shift Workers
Part of paid clinical trials in Fairborn, Ohio.
- Sponsor
- Wright State University
- Study ID
- NCT04122456
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 40 Years
- Healthy Volunteers
- Accepted
Interventions
- Ultraviolet B Radiation — RADIATIONOne skin punch biopsy will be taken to the laboratory for exposure to ultraviolet B radiation. After 1-hour incubation, the biopsies will be bisected in half.
- No Ultraviolet B Radiation — OTHEROne skin punch biopsy will be taken to the laboratory and will be kept as a non-irradiated control.
Study Details
The purpose of this study is to test how the skin of night shift workers responds to artificial sunlight (ultraviolet B radiation; UVB) at two different times of the day in comparison to normal day shift workers. After the skin biopsies are obtained, they will be brought to the laboratory to be exposed to UVB radiation and to measure UVB responses.
Key Dates
- Start date
- Dec 7, 2022
- Status verified
- Feb 2025
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 48 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Day Shift Work ScheduleDay shift worker skin biopsies will be exposed to artificial sunlight (ultraviolet B radiation; UVB) at the laboratory.
- Experimental: Night Shift Work ScheduleNight shift worker skin biopsies will be exposed to artificial sunlight (ultraviolet B radiation; UVB) at the laboratory.
Primary Outcome Measure
Expression level of the DNA repair factor XPA at two times of the day in the skin of day and night shift workers. [ Time Frame: After 1 hour incubation from ultraviolet B radiation exposure. ]
Central Contacts
- Manager, Clinical Research Operations937-245-7500
- Regulatory Specialist937-245-7500
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wright State Physicians | Fairborn | Ohio | 45324 | Pharmacology Translational Unit 937-245-7500 |
Find similar trials in Fairborn, OH
By condition
By specialty
By research site
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.PHASE1 · Recruiting · OncoNano Medicine, Inc. · Los Angeles, California
- Mechanisms for Laser-Induced RejuvenationRecruiting · Wright State University · Fairborn, Ohio
- Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer SurgeryEnrolling By Invitation · Memorial Sloan Kettering Cancer Center · Sacramento, California